Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in

  News Archive

Study Backs Flu Vaccinations for Elderly
Wednesday, August 26, 2015
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.

Inciting an Immune Attack on Cancer Cells
Wednesday, August 26, 2015
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.

Protein Found to Play a Key Role in Blocking Pathogen Survival
Wednesday, August 26, 2015
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.

MorphoSys and Immatics Enter Strategic Alliance in Immuno-oncology
Tuesday, August 25, 2015
Collaboration aims to develop novel antibody-based therapies targeting tumor-associated peptides derived from intracellular proteins.

Hepalink USA Agrees to Acquire Cytovance Biologics
Tuesday, August 25, 2015
Cytovance® Biologics, Inc., have announced that they have entered into a definitive agreement by which Hepalink USA Inc. will acquire Cytovance® Biologics Inc., a leading biopharmaceutical contract development manufacturing company.

Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Tuesday, August 25, 2015
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.

Immune System: Help for Killer Cells
Monday, August 24, 2015
A study from the University of Bonn may show the way to more effective vaccines.

Team Identifies Structure of Tumor-Suppressing Protein
Monday, August 24, 2015
An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN.

Researchers Publish Landmark “Basket Study”
Monday, August 24, 2015
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 1442

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos